Howard Horn
Net Worth
Last updated:
What is Howard Horn net worth?
The estimated net worth of Mr. Howard Horn is at least $4,608,843 as of 23 Feb 2023. He owns shares worth $1,003,597 as insider, has earned $196,096 from insider trading and has received compensation worth at least $3,409,150 in Vir Biotechnology, Inc..
What is the salary of Howard Horn?
Mr. Howard Horn salary is $681,830 per year as Chief Financial Officer & Sec. in Vir Biotechnology, Inc..
How old is Howard Horn?
Mr. Howard Horn is 47 years old, born in 1978.
What stocks does Howard Horn currently own?
As insider, Mr. Howard Horn owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Vir Biotechnology, Inc. (VIR) | Chief Financial Officer & Sec. | 230,712 | $4.35 | $1,003,597 |
What does Vir Biotechnology, Inc. do?
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 for the prevention of influenza A virus; and VIR-1111 for the prevention of human immunodeficiency virus. The company has grant agreements with Bill & Melinda Gates Foundation and National Institutes of Health; an option and license agreement with Brii Biosciences Limited and Brii Biosciences Offshore Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreements with The Rockefeller University and MedImmune, Inc.; collaboration with WuXi Biologics and Glaxo Wellcome UK Ltd.; and a collaborative research agreement with GlaxoSmithKline Biologicals SA. It also has a manufacturing agreement with Samsung Biologics Co.,Ltd. for the manufacture of SARS-COV-2 antibodies; and clinical collaboration with Gilead Sciences, Inc. for chronic hepatitis B virus. Vir Biotechnology, Inc. was incorporated in 2016 and is headquartered in San Francisco, California.
Howard Horn insider trading
Vir Biotechnology, Inc.
Mr. Howard Horn has made 9 insider trades between 2020-2023, according to the Form 4 filled with the SEC. Most recently he sold 2,248 units of VIR stock worth $58,387 on 23 Feb 2023.
The largest trade he's ever made was exercising 30,000 units of VIR stock on 25 Jun 2020. As of 23 Feb 2023 he still owns at least 230,712 units of VIR stock.
Vir Biotechnology key executives
Vir Biotechnology, Inc. executives and other stock owners filed with the SEC:
- Dr. George A. Scangos (77) Pres, Chief Executive Officer & Director
- Dr. Herbert W. Virgin IV (69) Executive Vice President of Research & Chief Scientific Officer
- Mr. Howard Horn (47) Chief Financial Officer & Sec.
- Mr. Steven J. Rice (65) Chief Admin. Officer